Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 14/20 | 0.45 |
| ▸ | CTSS | P25774 | 11/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28930599 | 1.00 | CTSK (0.45) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL22527164 | 0.85 | CA2 (0.40) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL6654092 | 0.83 | CTSK (0.58) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL3238391 | 0.81 | CTSS (0.50) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL3238402 | 0.81 | CTSS (0.50) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL16138557 | 0.80 | CTSK (0.41) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL2508772 | 0.80 | CTSS (0.50) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL8185522 | 0.80 | CTSK (0.60) | CTSKCTSS | |
| SCHEMBL165351 | 0.80 | CYP2D6 (0.53) | CTSKCTSSCTSLCTSBCA2 | |
| SCHEMBL165350 | 0.80 | CYP2D6 (0.53) | CTSKCTSSCTSLCTSBCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557871-A | Synthesis method of antiviral compound PF-07321332 | 杭州科巢生物科技有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-115557871-B | Synthesis method of antiviral compound PF-07321332 | 杭州科巢生物科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-115557871-B | Synthesis method of antiviral compound PF-07321332 | 杭州科巢生物科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-115557871-A | Synthesis method of antiviral compound PF-07321332 | 杭州科巢生物科技有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-115557871-A | Synthesis method of antiviral compound PF-07321332 | 杭州科巢生物科技有限公司 | 2023-01-03 | — | — | CN | disclosed |